Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Acquisition

30 Mar 2012 07:00

Anpario plc ("Anpario", the "Company" or the "Group")

Acquisition of Meriden Animal Health Limited

Highlights

Acquisition of Meriden Animal Health Limited ("Meriden") for up to £4.125 million Meriden's 2011 sales and adjusted profit before interest and tax were £5.35 million and £740,000 respectively Expected to be immediately earnings enhancing Deal increases Anpario's global market share and significantly strengthens its position in China Consideration to be met from the Company's existing cash resources

Anpario plc, one of the leading suppliers of natural high performance feed additives to enhance health, growth and sustainability in global agriculture and aquaculture markets, is pleased to announce the acquisition of Meriden Animal Health Limited for a total consideration of up to £4.125 million.

The acquisition of Meriden brings another strong trading brand to the Anpario Group, broadening its product technology and increasing Anpario's global market share in the feed additive sector.

Meriden based in Bedfordshire in the United Kingdom, supplies the global agriculture and aquaculture markets with natural animal feed additive products. Meriden's Orego-Stim range of products, using essential oils, is the leading brand in its field and is marketed across 60 countries worldwide, with the majority of sales being outside the United Kingdom

Meriden's sales for the 12 months to December 2011 were £5.35 million and adjusted profit before interest and tax was £740,000. Net assets acquired will be at least £1.644 million, the majority being working capital, including cash in excess of £400,000. The acquisition is expected to be immediately earnings enhancing to the Group as a whole.

Meriden has ten full time staff including a technical support team based in a representative office in Malaysia. The majority of production is outsourced to a third party manufacturer based in the United Kingdom. Meriden typically supplies through distributors in the local territories except Australia where the company has a joint venture company.

Meriden has a close and important partnership with its China operation with sales accounting for 26% of Meriden's total sales during 2011. The China business has been growing well and Anpario intends to give further support to this relationship to capitalise on the vast potential of China's agriculture market.

In line with Anpario's strategy, Meriden will be run as a separate business enabling the team to focus on selling and marketing high quality feed additive products around the world. Joining Anpario means Meriden's management team will gain additional support and can benefit from working together with Anpario's research and development resource to develop new and innovative products for sale under the Meriden brand.

The two shareholders and founders, namely, Stephen Harris, Managing Director, and Pamela McLaren, Company Secretary, are to remain with the business in their existing roles and will continue to develop the Meriden business further.

The price payable for Meriden is on a debt free basis but will include estimated excess cash of £400,000. An initial payment of £3.0 million in cash on completion has been made from existing cash resources. The remaining £1.125 million is payable over the next two years, dependent on Meriden achieving certain performance criteria, and of this, £125,000 is to be satisfied by the issue of ordinary shares of Anpario to Meriden's shareholders. Subsequent to the completion of this acquisition, Anpario's cash balances will be in excess of £2.5 million.

The Company expects to announce its results for the year ended 31 December 2011 on 26 April 2012.

Richard Edwards, Executive Vice Chairman of Anpario, commented:

"Meriden Animal Health is a quality business with strong brand recognition for developing 100% natural feed additives. This acquisition increases our global market share in animal feed additives which is benefiting as the agriculture industry looks to use natural based solutions to promote the health and growth of animals for meat consumption.

Meriden's significant presence in China increases our involvement in the world's biggest producer of poultry and pig meat and reinforces our strategy to build more significant positions in emerging agriculture and aquaculture markets. We are delighted to welcome the Meriden team and very much look forward to working with them in achieving continued success with the business."

Enquiries:

Anpario plcRichard Edwards, Executive Vice Chairman +44 (0)7776 417129Karen Prior, Group Finance Director +44 (0)1909 537380

FinnCap +44 (0)20 7600 1658Matthew Robinson / Henrik Persson - Corporate FinanceStephen Norcross - Corporate Broking

Copyright Business Wire 2012

Date   Source Headline
17th Mar 20217:01 amRNSDirectorate Change
17th Mar 20217:00 amRNSFinal Results
15th Mar 20213:38 pmRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSDirectorate Change
4th Feb 20212:54 pmRNSBlock Listing Application
3rd Feb 20214:52 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:30 pmRNSTotal Voting Rights
26th Jan 20217:00 amRNSTrading Statement and Board update
25th Jan 20217:00 amRNSDirectorate Change
18th Jan 20217:00 amBUSBlock listing Interim Review
8th Jan 20217:00 amBUSDirectorate change
9th Dec 202010:55 amBUSTotal Voting Rights
5th Nov 20205:03 pmBUSDirector/PDMR Shareholding
3rd Nov 202010:06 amRNSTotal Voting Rights
16th Oct 20201:22 pmRNSLady Oregon Goes Aloft
9th Oct 20207:17 amRNSDirector/PDMR Shareholding
2nd Oct 202012:13 pmRNSTotal Voting Rights
24th Sep 20207:00 amRNSChange of auditor
18th Sep 20204:24 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amBUSHalf-year Report
17th Jul 202010:55 amRNSBlock listing Interim Review
7th Jul 20201:43 pmRNSTotal Voting Rights
3rd Jul 20203:42 pmRNSHolding(s) in Company
3rd Jul 20202:42 pmRNSHolding(s) in Company
25th Jun 20202:13 pmRNSResult of the AGM
25th Jun 20207:00 amRNSAGM Statement
18th Jun 20205:06 pmRNSHolding(s) in Company
1st May 20205:43 pmBUSNotice of AGM
1st May 202010:16 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCOVID-19 Update and Patent Application
7th Apr 20208:45 amRNSTotal Voting Rights
18th Mar 20207:00 amBUSFinal Results
13th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20207:00 amRNSCompletion of Buyback Programme
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSTransaction in Own Shares
2nd Mar 20207:00 amRNSTransaction in Own Shares
25th Feb 20207:00 amRNSTransaction in Own Shares
24th Feb 20207:00 amRNSTransaction in Own Shares
20th Feb 20203:11 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSTransaction in Own Shares
12th Feb 20207:00 amRNSTransaction in Own Shares
7th Feb 20203:31 pmRNSHolding(s) in Company
7th Feb 202011:16 amRNSHolding(s) in Company
7th Feb 20207:00 amRNSTransaction in Own Shares
5th Feb 20205:14 pmRNSShare Buyback Programme
5th Feb 20209:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.